Global HAPPI Conference and Cosmetic Ingredients Conference Headlines ROOT OF SKIN Skincare Scientists As Keynote Speakers

AIVITA Biomedical Scientists Invited to Deliver Keynote Address at HAPPI Anti-Aging Conference

IRVINE, Calif. – March 21, 2018 – AIVITA Biomedical, a global biotech wellness company specializing in novel stem cell applications, announced today the appointment of its two senior scientists as keynote speakers at the HAPPI Anti-Aging Conference. Chief Science Officer Gabriel Nistor, M.D. and Vice President of Research and Development Aleksandra J. Poole, Ph.D. will deliver a keynote speech titled Biotechnology-derived Active Ingredients for Anti-Aging Cosmetics at the conference taking place May 15-16 at the Jacob Javits Convention Center in New York City.

Javits Graphic

HAPPI is the leading media outlet in the global personal care and household product market. HAPPI’s Anti-Aging Conference will give formulators and their suppliers an opportunity to learn, interact and discuss all things related to anti-aging with industry professionals. The conference will feature breakthrough technology, novel raw materials, regulatory insights and market research involving the multibillion-dollar anti-aging industry.

 In January Dr. Nistor and Dr. Poole introduced to consumers an all-new actives complex which utilizes the natural signaling methods and ingredients of skin stem cells to achieve more youthful-looking skin. The breakthrough active is available in the Company’s  ROOT OF SKIN™ product line.

“We’re grateful for the invitation and look forward to sharing some truly exciting innovations with the attendees,” said Dr. Nistor. “We hope our focus on providing proper nutriments to achieve results is a welcome shift from current, more damaging approaches.”

Dr. Hans Keirstead, CEO AIVITA Biomedical, will also appear on a promotional podcast with host Tom Branna in advance of the show, which will be made available on their website at http://www.happi.com and www.rootofskin.com

Hans For Beauty Independent
           Dr. Hans Keirstead                    CEO AIVITA Biomedical